OncoSec Medical Inc (ONCS)-医療機器分野:企業M&A・提携分析

◆英語タイトル:OncoSec Medical Inc (ONCS) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8011394
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月22日
◆ページ数:49
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
OncoSec Medical Inc (OncoSec) is a biotechnology company that offers services to stimulate body’s immune system and attack cancer. It’s lead candidate, ImmunoPulse IL-12, consists of a plasmid construct encoding the proinflammatory cytokine, IL-12, which is delivered into the tumor through in vivo electroporation. OncoSec is conducting pipeline programs for various indications which include metastatic melanoma, triple negative breast cancer and solid tumors. It is also identifying and developing novel immune-targeting agents for use with the ImmunoPulse platform. The company conducts pre-clinical and clinical studies targeting various cancers in collaboration with various academic medical centers and companies. OncoSec is headquartered in San Diego, California, the US.

OncoSec Medical Inc (ONCS) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
OncoSec Medical Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 6
OncoSec Medical Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 7
OncoSec Medical Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 8
OncoSec Medical Inc, Medical Equipment, Deals By Market, 2011 to YTD 2017 9
OncoSec Medical Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 10
OncoSec Medical Inc, Medical Equipment, Deal Details 11
Partnerships 11
OncoSec Medical Enters into Agreement with Jounce Therapeutics 11
OncoSec Medical Enters into Agreement with Inhibrx 12
OncoSec Medical Enters into Research Agreement with University of California and PerkinElmer 13
OncoSec Medical Enters Into Research Agreement With Serametrix 14
Equity Offering 15
OncoSec Medical Plans to Raise up to USD16 Million in Public Offering of Shares 15
OncoSec Medical to Raise USD9.3 Million in Private Placement of Shares upon Exercise of Warrants 16
OncoSec Medical Raises USD7 Million in Private Placement of Shares 17
Oncosec Medical Raises USD5 Million in Private Placement of Shares upon Exercise of Warrants 19
OncoSec Medical Plans to Raise up to USD8.4 Million in Public Offering of Shares 20
OncoSec Medical Raises USD10 Million in Registered Direct Offering 21
OncoSec Medical Raises USD13.6 Million in Private Placement of Shares 22
OncoSec Medical Raises USD16 Million in Private Placement of Shares and Warrants 23
OncoSec Medical Completes Private Placement Of Shares For US$12 Million 24
OncoSec Medical Completes Private Placement Of Common Stock For US$7 Million 25
OncoSec Medical Completes Public Offering Of Units For US$8 Million 26
OncoSec Medical Completes Private Placement Of US$3 Million 28
OncoSec Medical Completes Private Placement Of US$1.09 Million 29
OncoSec Medical Inc – Key Competitors 30
OncoSec Medical Inc – Key Employees 31
OncoSec Medical Inc – Locations And Subsidiaries 32
Head Office 32
Recent Developments 33
Financial Announcements 33
Jun 01, 2017: OncoSec Announces Third Quarter and YTD Results for Fiscal Year 2017 33
Mar 16, 2017: OncoSec Announces Second Quarter and YTD Results for Fiscal Year 2017 35
Dec 08, 2016: OncoSec Announces First Quarter Financial Results for Fiscal Year 2017 36
Oct 13, 2016: OncoSec Announces Fourth Quarter and Year End Results for Fiscal Year 2016 37
Jun 09, 2016: OncoSec Announces Third Quarter and YTD Results for Fiscal Year 2016 38
Mar 08, 2016: OncoSec Announces Second Quarter and YTD Results for Fiscal Year 2016 and Calendar 2016 Milestones 39
Corporate Communications 40
Dec 05, 2017: OncoSec Announces Promotion of Christopher G. Twitty, Ph.D. to CSO 40
Nov 07, 2017: OncoSec Appoints Daniel J. O’Connor as Chief Executive Officer to Lead Next Stage of Growth as a Fully Integrated Late Stage Development and Commercial Company 41
Sep 07, 2017: OncoSec Appoints Industry Leader Daniel J. O’Connor to its Board of Directors 42
Sep 06, 2016: OncoSec Appoints Sharron Gargosky, PhD, to Chief Clinical and Regulatory Officer 43
Apr 15, 2016: OncoSec Announces New Senior Leadership Responsibilities 44
Feb 29, 2016: OncoSec Appoints Sharron Gargosky, PhD, as Head of Clinical Development and Operations 45
Product News 46
Nov 28, 2017: OncoSec Expands Intellectual Property Estate, Announces Issuance of Patents for ImmunoPulse® Platform 46
May 02, 2017: OncoSec to Present at Biomarkers & Immuno-Oncology World Congress 2017 47
Jun 28, 2016: OncoSec Presents Significant Advancements in Electroporation Technology for Immunotherapy 48
Appendix 49
Methodology 49
About GlobalData 49
Contact Us 49
Disclaimer 49

List of Tables
OncoSec Medical Inc, Medical Equipment, Key Facts, 2017 2
OncoSec Medical Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
OncoSec Medical Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 6
OncoSec Medical Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 7
OncoSec Medical Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 8
OncoSec Medical Inc, Deals By Market, 2011 to YTD 2017 9
OncoSec Medical Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 10
OncoSec Medical Enters into Agreement with Jounce Therapeutics 11
OncoSec Medical Enters into Agreement with Inhibrx 12
OncoSec Medical Enters into Research Agreement with University of California and PerkinElmer 13
OncoSec Medical Enters Into Research Agreement With Serametrix 14
OncoSec Medical Plans to Raise up to USD16 Million in Public Offering of Shares 15
OncoSec Medical to Raise USD9.3 Million in Private Placement of Shares upon Exercise of Warrants 16
OncoSec Medical Raises USD7 Million in Private Placement of Shares 17
Oncosec Medical Raises USD5 Million in Private Placement of Shares upon Exercise of Warrants 19
OncoSec Medical Plans to Raise up to USD8.4 Million in Public Offering of Shares 20
OncoSec Medical Raises USD10 Million in Registered Direct Offering 21
OncoSec Medical Raises USD13.6 Million in Private Placement of Shares 22
OncoSec Medical Raises USD16 Million in Private Placement of Shares and Warrants 23
OncoSec Medical Completes Private Placement Of Shares For US$12 Million 24
OncoSec Medical Completes Private Placement Of Common Stock For US$7 Million 25
OncoSec Medical Completes Public Offering Of Units For US$8 Million 26
OncoSec Medical Completes Private Placement Of US$3 Million 28
OncoSec Medical Completes Private Placement Of US$1.09 Million 29
OncoSec Medical Inc, Key Competitors 30
OncoSec Medical Inc, Key Employees 31

★海外企業調査レポート[OncoSec Medical Inc (ONCS)-医療機器分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • AMAG Pharmaceuticals Inc:企業の戦略的SWOT分析
    AMAG Pharmaceuticals Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • Pattern Energy Group Inc (PEGI):企業の財務・戦略的SWOT分析
    Pattern Energy Group Inc (PEGI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • Punjab National Bank (PNB):電力:M&Aディール及び事業提携情報
    Summary Punjab National Bank (PNB) offers retail and commercial banking, agricultural and international banking, and other financial services. Its retail and commercial banking portfolio offers credit and debit cards, corporate and retail loans, deposit services, cash management, and export and impo …
  • Anglo Pacific Group plc:企業のM&A・事業提携・投資動向
    Anglo Pacific Group plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Anglo Pacific Group plc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisition …
  • Conair Corporation
    Conair Corporation - Strategy, SWOT and Corporate Finance Report Summary Conair Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Precision System Science Co Ltd (7707):企業の財務・戦略的SWOT分析
    Summary Precision System Science Co Ltd (PSS) is a medical device company that develops, manufactures and sells automated systems, physicochemical instruments, software, and others. The company provide products such as automated nucleic acid isolation system, large sample volume nucleic acid extract …
  • Paramedical Srl:企業の製品パイプライン分析2018
    Summary Paramedical Srl (Paramedical) is a medical equipment company that manufactures clinical chemistry, turbidimetry and instruments for laboratories. The company’s products include in vitro diagnostics and equipment, automated immunoassay, brochure regents and instruments, centrifuges, chemistry …
  • Koninklijke Philips N.V. (PHIA):電力:M&Aディール及び事業提携情報
    Summary Koninklijke Philips N.V. (Philips) is a diversified technology company develops and manufactures medical systems, consumer electronics and lighting products. The company offers patient care & clinical informatics, imaging systems, healthcare transformation services and home healthcare soluti …
  • Ellex Medical Lasers Limited (ELX):企業の財務・戦略的SWOT分析
    Ellex Medical Lasers Limited (ELX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Abu Dhabi National Energy Co (TAQA):電力:M&Aディール及び事業提携情報
    Summary Abu Dhabi National Energy Company (TAQA), a subsidiary of government-owned Abu Dhabi Water and Electricity Authority, is an energy and water company. It undertakes power generation; exploration, development, production and storage of oil and gas; pipelines and gas storage; and water desalina …
  • CNOOC Limited:企業の戦略・SWOT・財務分析
    CNOOC Limited - Strategy, SWOT and Corporate Finance Report Summary CNOOC Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Rebiotix Inc-製薬・医療分野:企業M&A・提携分析
    Summary Rebiotix Inc (Rebiotix), formerly MikrobEX Inc is a clinical stage biotechnology company that offers treatment solutions for debilitating diseases by harnessing the power of the human microbiome. The company harnesses microbiota restoration therapy, a drug delivery platform that releases hea …
  • NuGEN Technologies Inc-医療機器分野:企業M&A・提携分析
    Summary NuGEN Technologies Inc (NuGEN) is a provider of biological science reagents. The company offers DNA and RNA sample preparation products for use in research and diagnostic applications. Its products include Next-Gen Sequencing applications, which include RNA-Seq, targeted resequencing of DNA …
  • Grupo Argos SA:企業の戦略・SWOT・財務分析
    Grupo Argos SA - Strategy, SWOT and Corporate Finance Report Summary Grupo Argos SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Kuzbasskaya Toplivnaya Company:企業の戦略・SWOT・財務分析
    Kuzbasskaya Toplivnaya Company - Strategy, SWOT and Corporate Finance Report Summary Kuzbasskaya Toplivnaya Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Viettel Group:企業の戦略・SWOT・財務分析
    Viettel Group - Strategy, SWOT and Corporate Finance Report Summary Viettel Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Nordson Corporation:企業のM&A・事業提携・投資動向
    Nordson Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Nordson Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), …
  • Duvel Moortgat NV:企業の戦略的SWOT分析
    Duvel Moortgat NV - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and serv …
  • Sinclair Broadcast Group Inc (SBGI):企業の財務・戦略的SWOT分析
    Summary Sinclair Broadcast Group Inc (Sinclair) is a television broadcasting service provider that owns and operates television programs. The company's service portfolio includes content creation, distribution platforms, advertising platform and technical solutions. It offers content across various …
  • Arkle Resources Plc:企業の戦略・SWOT・財務分析
    Arkle Resources Plc - Strategy, SWOT and Corporate Finance Report Summary Arkle Resources Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆